Member Info for NCTrade

These guys spend their whole day hogging the bb for their own gain, waiting for the weak holders to sell so they could buy in as cheaply as possible then go all super positive.

Don’t be fooled by their tactics.

Watch the latest interview and decide for yourself.

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38 he confirms the following:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

Don’t give your shares away to the derampers who are waiting on the sidelines to buy back in as cheap as possible then go ultra positive…

That’s brilliant news CDF1

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

Watch the interview, Vlad confirming discussions with large pharmaceutical companies.

He couldn’t be anymore clearer than what he said in the interview.

https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview and listen to the scientist behind this company.

The treatments he is talking about are worth several hundred million, potentially more.

Large pharmaceutical companies have been busy buying up smaller companies paying hundreds of millions and some cases over a billion.

Today’s prices is an absolute gift.

Some have the capacity to invest and want to see a return on their investment, and some others who do not have any funds will forever be busy making noise in the background wishing they could join this journey :-)))

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

Thanks for sharing these fantastic updates.

The RNS that was issued on the 15th Oct 25 claimed:

Sunda is on track to sign a rig contract before the end of 2025.

Sunda continues to engage with the Timor-Leste helicopter company for support of the planned offshore drilling operations at Chuditch and believes that an appropriate and safe service is now going to be available for the planned drilling period.

The Environmental Permitting process is progressing well and SundaGas anticipates award during Q4 2025.

These could be announced anytime now.

Andy Butler is one of the speakers at the exhibition, all eyes would be on him from many major companies being in audience too…

It’s getting very exciting now :-)))

Forgot to add that the person had paid around $20 dollars per Bitcoin back then only to watch it sky rocket to tens of thousands of pounds later on.

Those sitting on the fence will one day wake up to a whopping re-rate and will watch helplessly the share price sky rocket :-)))

Someone I know owned between 60,000-65,000 bitcoins around the time when hardly anyone had heard of them.

He believed the scaremongering tactics back then, and decided to cash them all in for a measly profit, feeling quite pleased at the time and relieved that he managed to get his money back.

Same person had been struggling mentally since after the price of Bitcoin had sky rocketed over the years, and he deeply regrets believing all the scaremongering tactics as it would have been life changing money for his entire family and future generations to come.

There are lessons to be taken from this; often it is better not to do anything/over think and leave the investment alone awaiting a ground breaking deal.

Hemogenyx is on the cusp of greatness, Vlad already revealed at his recent interview confidently stating that he was in discussion with large pharmaceutical companies suggesting there’s more than one he is negotiating with, and the pharmaceutical companies he said would be looking to either license or acquire these treatments.

Hemo is scaling up its business with other products that they have adding even further value to its business.

Pharmaceutical companies may weigh up the option of paying several hundred millions now rather than pay billions at a later time.

Your £8 a share today could be worth £100 in the very near future that would be life changing money for the majority of shareholders :-)))

Thanks for sharing these updates ikibr9, filthy and CDF1, extremely positive and we could be in for a cracker before the end of the year :-))

AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions that also yielded positive results for a late-stage rare disease drug.

A small family owned company founded only 4 years a go with 3 clinical candidates managed to bag a major billion dollar deal with AstraZeneca who claimed they negotiated the deal quickly after seeing present data from its first patient.

Deals are being done for such small companies and Vlad clearly dropped a hint in his recent interview that he is discussing with pharma companies, don’t be surprised if a deal is forthcoming :-)))

Syed T. Husain, Chairman & CEO of Made Scientific, commented:

“Our collaboration with Hemogenyx reflects Made Scientific’s commitment to advancing next-generation cell therapies that address urgent, unmet medical needs.

Through our integrated development and manufacturing solutions and highly experienced team, we are proud to support Hemogenyx as they advance HG-CT-1 in their Phase I clinical trial.”

Dr. Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, said:

“Partnering with a trusted CDMO like Made Scientific is essential to the success of HG-CT-1, our lead CAR-T therapy.

Made’s expertise in cell therapy manufacturing will be instrumental in driving the continued progress of this potential breakthrough therapy for patients with relapsed or refractory AML.”

Through this partnership, Made Scientific remains focused on its mission: Defy Limits. Deliver Results.

One of these days, you’ll suddenly wake up to a 7am RNS with a blockbuster deal so better to be in than out.

Car T-Cell Therapy Market size is set to grow by USD 3.02 billion.

The total market value for CAR T-cell therapy is estimated to be around $4.20-$4.65 billion in 2024-2025, with projections to grow to over $100 billion by 2034.

The projected values differ based on the report and forecast period, with some predicting significant growth to over $223 billion by 2034.

Vlad is working towards making Hemogenyx worth billions.

Already mentioned in his recent interview that he is engaged in discussing with a pharma company…

How did some fall for their dirty tactics.

Those two individuals stayed up all night posting like a maniac trying every dirty tactic to get the sells in so that they can manipulate their way into buying on the cheap.

The price action is showing a positive upward movement now with loads hoovering up the shares at these prices.

Ask and Bid will nudge upwards now

I find it strange why Aldebaran did not sell his entire holding as he claims at 1600, having this foresight that it will drop down to 1000 so he claims…that bit doesn’t make any sense unless it’s all bs of course :-)))

The two individuals caused panic and fear among some investors here and some sold, only to allow the two individuals to buy in at a market low.

Those two have completely played you…

Follow the science, not the two that stayed up all night panicking on how to close their shorts in case the price went up.

Goodness me, those two poor sods between them lost sleep, they’d been busy posting non stop drivel when the markets been closed knowing a TR1 is incoming and spreading fear, uncertainty and doubt.

TR1 incoming dudes, close the shorts lol

Well the herd have now heard and now here wanting a piece of the pie.

Rig contract and Environmental permit due anytime now as confirmed in the company news release.

In a few days time the exhibition seminar is taking place with a lot of big market players in attendance.

Andy Butler is one of the speakers :-)))

Check out Sunda energy

JV leak, price moving up at rapid pace